| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 18.05.
| Top Insider Trades On May 17: Buying At Hess And Halozyme | | 10 | Seeking Alpha |
| 17.05.
| Halozyme Therapeutics Has Returned 33.0% Since SmarTrend Recommendation | | 1 | SmarTrend |
| 09.05.
| Halozyme Therapeutics Shares Down 32.3% Since SmarTrend's Sell Call | | 2 | SmarTrend |
| 09.05.
| Halozyme Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | | 8 | PR Newswire |
| SAN DIEGO, May 9, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas on Wednesday, May...
Mehr lesen zu:
Halozyme Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | |
| 07.05.
| Halozyme Reports First Quarter 2012 Financial Results | | 28 | PR Newswire |
| SAN DIEGO, May 7, 2012 /PRNewswire/ --Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the quarter ended March 31, 2012.
(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)
"We...
Mehr lesen zu:
Halozyme Reports First Quarter 2012 Financial Results | |
| 30.04.
| Halozyme to Host First Quarter 2012 Financial Results Conference Call | | 18 | PR Newswire |
| SAN DIEGO, April 30, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2012 on Monday, May 7, 2012 at 4:30 p.m....
Mehr lesen zu:
Halozyme to Host First Quarter 2012 Financial Results Conference Call | |
| 25.04.
| Halozyme Therapeutics Has Returned 27.0% Since SmarTrend Recommendation | | 1 | SmarTrend |
| 17.04.
| Downgrade Alert for Halozyme Therapeutics | | 8 | SmarTrend |
| 16.04.
| XFRA 7FA,1IC,9EY,RV7: WIEDERAUFNAHME/RESTART | | 67 | Xetra Newsboard |
| DIE FOLGENDE AKTIE WIRD MIT SOFORTIGER WIRKUNG WIEDER IN DEN HANDEL
AUFGENOMMEN:
THE FOLLOWING SHARE IS RESUMED TRADING WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
Halozyme RV7...
Mehr lesen zu:
XFRA 7FA,1IC,9EY,RV7: WIEDERAUFNAHME/RESTART | |
| 16.04.
| Analysis of Relative Performance in the Healthcare Sector for Shares of Halozyme Therapeutics | | 3 | SmarTrend |
| 16.04.
| Halozyme Therapeutics Falling Today on Above-Average Volume | | 1 | SmarTrend |
| 16.04.
| Halozyme Therapeutics Makes a Move: Down 20.8% | | 2 | SmarTrend |
| 16.04.
| Baxter, Halozyme Issue Update On HyQ Biologics License Application | | 65 | AFX News |
| DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) and Halozyme
Therapeutics, Inc. (HALO) announced that the U.S. Food and Drug Administration,
or FDA, is requesting additional information...
Mehr lesen zu:
Baxter, Halozyme Issue Update On HyQ Biologics License Application | |
| 16.04.
| Baxter and Halozyme Provide Update on HyQ Biologics License Application | | 40 | Business Wire |
| Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc.
(NASDAQ:HALO) today announced that the U.S. Food and Drug Administration
(FDA) is requesting additional...
Mehr lesen zu:
Baxter and Halozyme Provide Update on HyQ Biologics License Application | |
| 16.04.
| Baxter (BAX), Halozyme (HALO) Announce FDA Request for More Info on HyQ Biologics Application | | 2 | StreetInsider.com |
| 16.04.
| XFRA RV7: AUSSETZUNG/SUSPENSION | | 26 | Xetra Newsboard |
| DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT:
THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
HALOZYME THERAPEUTICS INC RV7 US40637H1095...
Mehr lesen zu:
XFRA RV7: AUSSETZUNG/SUSPENSION | |
| 16.04.
| Baxter and Halozyme Provide Update on HyQ Biologics License Application | | 16 | PR Newswire |
| DEERFIELD, Ill. and SAN DIEGO, Calif., April 16, 2012 /PRNewswire/ -- Baxter International Inc. (NYSE: BAX) and Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and...
Mehr lesen zu:
Baxter and Halozyme Provide Update on HyQ Biologics License Application | |
| 10.04.
| Halozyme Therapeutics Plunges On Jefferies Downgrade | | - | SmarTrend |
| 10.04.
| Halozyme Therapeutics Falling Today on Above-Average Volume | | 2 | SmarTrend |
| 10.04.
| Stock Investors Sell Off Shares of Halozyme Therapeutics, Down 3.5% | | 2 | SmarTrend |
